On 2025-05-07, Cognition Therapeutics, Inc. (CGTX) announced earnings per share of $-0.14 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.12.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.11 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.12 | $-0.14 |
| 2025-03-20 | 2024-12-31 | $-0.16 | $-0.17 |
| 2024-11-13 | 2024-09-30 | $-0.24 | $-0.25 |
| 2024-08-08 | 2024-06-30 | $-0.22 | $-0.18 |
| 2024-05-07 | 2024-03-31 | $-0.23 | $-0.27 |
| 2024-03-26 | 2023-12-31 | $-0.38 | $-0.27 |
| 2023-11-02 | 2023-09-30 | $-0.31 | $-0.22 |
| 2023-08-08 | 2023-06-30 | $-0.25 | $-0.16 |
| 2023-05-04 | 2023-03-31 | $-0.17 | $-0.21 |
| 2023-03-23 | 2022-12-31 | $-0.49 | $-0.20 |
| 2022-11-14 | 2022-09-30 | $-0.55 | $-0.29 |
| 2022-08-09 | 2022-06-30 | $-0.31 | $-0.25 |
| 2022-05-11 | 2022-03-31 | $-0.27 | $-0.17 |
| 2021-11-18 | 2021-09-30 | $-0.57 | $-8.12 |